Alexandria Capital »

Intellia Therapeutics shares owned by Alexandria Capital

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Alexandria Capital from 13F filings

Historical chart of Alexandria Capital investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Alexandria Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Alexandria Capital

Quarter filed Position value Share count Share price at filing
2021-09-30 $215k 1.6k 134.38
2021-06-30 $278k 1.7k 161.63

More positions owned by Alexandria Capital

Adobe Systems Incorporated (ADBE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Alnylam Pharmaceuticals (ALNY)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard World Mega Grwth Ind (MGK)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Facebook Cl A (META)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Comcast Corp Cl A (CMCSA)
JPMorgan Chase & Co. (JPM)
Marvell Technology (MRVL)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)

View all positions for Alexandria Capital

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
BlackRock
Vanguard Group
Deep Track Capital
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Federated Investors
Geode Capital Management
Morgan Stanley
Contrarius Investment Management
Casdin Capital
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Intellia Therapeutics